Jenburkt Pharmaceuticals Limited
Pharmaceuticals - Formulations BSE:524731 NSE:NA Bloomberg:JBP@IN Reuters:JENA.BO Market Lot: 1 Face Value: 10 ISIN Demat: INE354A01013
Company Announcements
Board Meeting Intimation for Inter-Alia, To Take On Record The Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December, 2023.
19-JAN-24
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11-JAN-24
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
30-DEC-23
Closure of Trading Window
19-DEC-23
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
15-DEC-23
Announcement under Regulation 30 (LODR)-Newspaper Publication
08-NOV-23
Standalone Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2023
07-NOV-23
Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E. 07Th November, 2023 - Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2023.
07-NOV-23
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
01-NOV-23
Board Meeting Intimation for Inter-Alia, To Take On Record The Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2023.
27-OCT-23
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11-OCT-23
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
29-SEP-23